Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on March 13, 2020.
March 26, 2020 at 03:23 am EDT
Share
From March 13, 2020 to March 25, 2020, the company has repurchased 104,712 shares, representing 1.42% for KRW 819.49 million. With this, the company has completed the repurchase of 104,712 shares, representing 1.42% for KRW 819.49 million under the buyback announced on March 13, 2020.
Yuyu Pharma, Inc. is a Korea-based company engaged in the provision of pharmaceutical products. The Company produces prescription drugs such as circulatory improvement agents, antiplatelet agents, osteoporosis drugs, antiulcerants, bone metabolism ameliorants, gout preparative drugs, antidepressants, anti-diabetic agents, antitubercular agents, antihypertensive agents, angina pectoris drugs, antibiotics, hemorrhoidal and varicose preparations, topical corticosteroids and others, as well as non-prescription drugs such as vitamins and digestive agents. It also provides healthcare supplements and quasi drugs. In addition, the Company is involved in the provision of medicines for geriatric diseases such as osteoporosis, dementia, stroke and others.
YUYU PHARMA, INC. 
